Skip to Content

Whistleblower Qui Tam Representative Settlements

State of California v. Schering-Plough Corporation

Status:Settled
Settlement Amount: $21.3 million
Practice Area(s): Whistleblower, Qui Tam & False Claims Act
On December 17, 2009, Schering-Plough Corporation (now known as Merck & Co.) agreed to pay $21.3 million to settle qui tam allegations that it knowingly inflated the prices of its drugs, causing California's Medicaid Program, Medi-Cal, to overpay...

State of Florida v. Dey

Status:Settled
Settlement Amount: $6.5 million
Practice Area(s): Whistleblower, Qui Tam & False Claims Act
The State of Florida recently settled a whistleblower case against three pharmaceutical manufacturers and their corporate affiliates. The case, which was originally filed by a whistleblower represented by the Whistleblower / Qui Tam Group, involved...

U.S. ex rel. John Doe v. Recovery Home Care, Mark Conklin, and Glen Castillo

Status:Pending
Practice Area(s): Whistleblower, Qui Tam & False Claims Act
RHC violated the False Claims Act by provided remuneration to physicians to induce patient referrals and reward physicians for prior referrals in violation of the Anti- Kickback Statute ("AKS"), 42 U.S.C. § 1320a-7b and the Stark Law, 42 U.S.C. § 1395nn.

United States et al. ex rel. Ronald J. Streck v. Allergan, Inc. et al.

Status:Pending
Practice Area(s): Whistleblower, Qui Tam & False Claims Act
This is a qui tam case brought by relator, Ronald J. Streck, on behalf of the United States and 25 states against thirteen pharmaceutical manufacturers for knowingly reporting materially inaccurate Average Manufacturer’s Prices (AMPs) for their drugs and thereby, fraudulently underpaying rebates owed to the Government Plaintiffs under the Medicaid Drug Rebate Program (the “Rebate Program”).

United States ex rel. Gale v. Omnicare, Inc.

Status:Settled
Practice Area(s): Whistleblower, Qui Tam & False Claims Act
False Claims Act case filed in the Northern District of Ohio on behalf of whistleblower Don Gale agains tOmnicare, Inc. The Complaint alleges that Omnicare violated the Anti-Kickback Statute by offering steeply discounted rates to nursing homes' Medicare Part A patients in exchange to serve the nursing home's Medicaid and Medicare Part D patients. The case settled for $120 Million.

United States ex rel. HMI v. Pinnacle Bank Lawsuit

Status:Pending
Practice Area(s): Whistleblower, Qui Tam & False Claims Act
The United States Government intervened in a case filed in the District of Wyoming under the False Claims Act, captioned United States ex rel. HMI v. Pinnacle Bank. According to the whistleblower’s complaint, Pinnacle violated the False Claims Act by withholding material information from and making materially false statements to the Small Business Administration (“SBA”) with regard to the funding of an SBA “504” loan.

United States ex rel. Ven-A-Care of the Florida Keys, Inc. v. Apothecon, Inc.

Status:Settled
Settlement Amount: $515 million
Practice Area(s): Whistleblower, Qui Tam & False Claims Act
Berger & Montague represented the whistleblower, Ven-A-Care of the Florida Keys, Inc., a small pharmacy from Key West, Florida. The case included allegations that Apothecon submitted false and inflated Average Wholesale Prices (AWPs) for a number of...

United States ex rel. Ven-A-Care of the Florida Keys, Inc. v. Bristol Myers Squibb Co.

Status:Settled
Settlement Amount: $515 million
Practice Area(s): Whistleblower, Qui Tam & False Claims Act
Berger & Montague represented the whistleblower, Ven-A-Care of the Florida Keys, Inc., a small pharmacy from Key West, Florida. The case included allegations that Bristol submitted false and inflated Average Wholesale Prices (AWPs) for a number of...

United States v. AstraZeneca Pharmaceuticals, LP

Status:Settled
Settlement Amount: $124 million
Practice Area(s): Whistleblower, Qui Tam & False Claims Act
In October 2009, the United States, through the U.S. Attorney's Office in New Hampshire, recovered $124 million from four drug companies -- Mylan Pharmaceuticals Inc., AstraZeneca Pharmaceuticals LP, UDL Laboratories Inc. and Ortho McNeil Pharmaceutical...

United States v. Aventis Pharmaceuticals Inc.

Status:Settled
Settlement Amount: $190 million
Practice Area(s): Whistleblower, Qui Tam & False Claims Act
In September 2007, Aventis Pharmaceuticals Inc. (now known as Sanofi-Aventis SA) paid $190 million to the United States, a number of states and the District of Columbia to settle a qui tam lawsuit alleging that the company caused false claims to be...